Literature DB >> 12866945

Exploring the demand for a voluntary Medicare prescription drug benefit.

Richard R Cline1, David A Mott.   

Abstract

The purposes of this study were (1) to assess the utility of the economic theory of demand for insurance for modeling voluntary Medicare drug benefit enrollment decisions and (2) to explore the degree of adverse selection and crowd-out that might occur under a voluntary enrollment Medicare prescription benefit. Data were collected using a cross-sectional, mail survey of 2,100 community-dwelling adults aged 65 and older in Wisconsin. Respondents were asked to evaluate their likelihood of enrollment in any of 4 hypothetical drug benefit plans under the assumption that they could enroll in one of the hypothetical plans or maintain their current coverage. Data analyses included bivariate comparisons across enrollment likelihood categories and logit analysis of enrollment likelihood as a function of respondent characteristics. 1041 usable survey forms were returned for an adjusted response rate of 51.5%. Older adults with 4 or more chronic conditions were most likely to report that they were "very likely" to enroll in one of the hypothetical drug plans, as were those with the highest out-of-pocket drug spending in the previous 30 days. Respondents with no or self-purchased drug benefits were more likely than those with employer-based plans to express a higher likelihood of enrollment in one of the hypothetical plans. Adverse selection may be problematic for a voluntary enrollment Medicare drug benefit. Given that high out-of-pocket drug spending (secondary to drug coverage source) was a consistent predictor of enrollment likelihood, demand-side factors affecting the crowding out of employer-based drug coverage sources by a voluntary enrollment drug benefit appear minimal. However, the availability of a Medicare prescription benefit may still lead to crowd-out through employer incentives.

Mesh:

Year:  2003        PMID: 12866945      PMCID: PMC2751526          DOI: 10.1208/ps050219

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  18 in total

1.  Medicare and prescription drugs.

Authors:  J K Iglehart
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  Growing differences between Medicare beneficiaries with and without drug coverage.

Authors:  J A Poisal; L Murray
Journal:  Health Aff (Millwood)       Date:  2001 Mar-Apr       Impact factor: 6.301

Review 3.  The Medicare prescription drug benefit: how will the game be played?

Authors:  H A Huskamp; M B Rosenthal; R G Frank; J P Newhouse
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

4.  A drug benefit: the necessary prescription for Medicare.

Authors:  J Rother
Journal:  Health Aff (Millwood)       Date:  1999 Jul-Aug       Impact factor: 6.301

5.  Designing a Medicare drug benefit: whose needs will be met?

Authors:  B Stuart; B Briesacher; D Shea
Journal:  Policy Brief Commonw Fund       Date:  2000-12

6.  State pharmaceutical assistance programs for older and disabled Americans.

Authors:  J Tilly; J M Wiener
Journal:  Health Aff (Millwood)       Date:  2001 Sep-Oct       Impact factor: 6.301

7.  A Medicare prescription drug benefit: focusing on coverage and cost.

Authors:  Juliette Cubanski; Janet Kline
Journal:  Issue Brief (Commonw Fund)       Date:  2002-04

8.  Prescription drug coverage and seniors: how well are states closing the gap?

Authors:  Dana Gelb Safran; Patricia Neuman; Cathy Schoen; Jana E Montgomery; Wenjun Li; Ira B Wilson; Michelle S Kitchman; Andrea E Bowen; William H Rogers
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Dec       Impact factor: 6.301

9.  Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999.

Authors:  Mary A Laschober; Michelle Kitchman; Patricia Neuman; Allison A Strabic
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Dec       Impact factor: 6.301

Review 10.  The case for a medicare drug coverage benefit: a critical review of the empirical evidence.

Authors:  A S Adams; S B Soumerai; D Ross-Degnan
Journal:  Annu Rev Public Health       Date:  2001       Impact factor: 21.981

View more
  2 in total

1.  Views of health system experts on macro factors of induced demand.

Authors:  Elahe Khorasani; Mahmoud Keyvanara; Saeed Karimi; Marzie Jafarian Jazi
Journal:  Int J Prev Med       Date:  2014-10

2.  Main Determinants of Supplementary Health Insurance Demand: (Case of Iran).

Authors:  Soraya Nouraei Motlagh; Hassan Abolghasem Gorji; Ghadir Mahdavi; Hossein Ghaderi
Journal:  Glob J Health Sci       Date:  2015-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.